
Article 1 
This Regulation lays down the procedures to be followed for the purpose of amending, at the request of an applicant, the Simplified Active Substance List under  Regulation (EU) No 528/2012 in order to:

((a)) include active substances in  category A or category B  of  the Simplified Active Substance List  in accordance with Article 28(1) of that Regulation; or
((b)) make amendments of the relevant restrictions in those categories.
Article 2 
An application for an inclusion or an amendment referred to in Article 1 shall include the information specified in the Annex to this Regulation.
Article 3 

1. The procedure laid down in Article 7(1) and... the third subparagraph of Article 7(3)... of Regulation (EU) No 528/2012 shall apply for the submission of applications for inclusions or amendments referred to in Article 1 of this Regulation.
2. Where the application concerns  category B  of  the Simplified Active Substance List under  Regulation (EU) No 528/2012, the first and second subparagraphs of Article 7(3) and Article 7(4) and (5) of that Regulation shall apply for the validation of the application.
Article 4 

1. The ... competent authority shall evaluate whether there is evidence that the substance does not give rise to concern in accordance with Article 28(2) of Regulation (EU) No 528/2012 and, where relevant, to which restrictions its use should be subject. It shall send an  opinion  to the  Secretary of State, the Scottish Ministers and the Welsh Ministers. Where the application concerns inclusion in  category A  of  the Simplified Active Substance List under  Regulation (EU) No 528/2012,  the opinion  shall be submitted within 180 days of the payment of the fees referred to in the third subparagraph of Article 7(3) of that Regulation. Where the application concerns inclusion in  category B  of  the Simplified Active Substance List under  Regulation (EU) No 528/2012,  the opinion  shall be submitted within 365 days of validation of that application.Prior to submitting its  opinion  to the  Secretary of State, the Scottish Ministers and the Welsh Ministers,, the ... competent authority shall give the applicant the opportunity to provide written comments on the  opinion  within 30 days. The ... competent authority shall take due account of those comments when finalising its  opinion.
2. Where it appears that additional information is necessary to  provide the opinion, the ... competent authority shall request that the applicant submit such information within a specified time limit.... The periods referred to in paragraph 1 of this Article shall be suspended from the date of issue of that request until the date the information is received. The suspension shall not exceed 180 days in total unless it is justified by the nature of the data requested or by exceptional circumstances.
3. An application concerning inclusion of an active substance in category A of  the Simplified Active Substance List under  Regulation (EU) No 528/2012, which, following a request for additional data pursuant to paragraph 2, complies fully with Article 6 of Regulation (EU) No 528/2012 shall, where the applicant so requests,
(a) be considered as an application for inclusion in category B of  the Simplified Active Substance List under  that Regulation; and
(b) be subject to validation pursuant to Article 3(2).
4. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Article 5 
Provided that there is evidence that an active substance does not give rise to concern within the meaning of Article 28(1) of Regulation (EU) No 528/2012, the Secretary of State may with the consent of  the Scottish Ministers and the Welsh Ministers, issue  a decision pursuant to that Article amending  the Simplified Active Substance List under  that Regulation in the sense referred to in Article 1 of this Regulation where the  competent authority  has submitted an opinion pursuant to:

((a)) Article 4 (1)  of this Regulation; or
((b)) Article 8(4) of Regulation (EU) No 528/2012...
((c)) ...
Article 6 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
...Done at Brussels, 31 January 2014.
For the Commission
The President
José Manuel BARROSO
ANNEX
SECTION A
1. 

((a)) that the substance complies with the description of the relevant category; and
((b)) that there is a robust consensus of expert opinion that the substance does not give rise to concern in accordance with Article 28(2) of that Regulation.

The evidence referred to in point (b) shall include all relevant published literature data regarding the substance in question and all relevant data on the substance generated by the applicant. It may also include read-across from chemical analogues/homologues, (Q)SAR predictions, data from existing studies, in vitro studies, historical human data, or conclusions from other regulatory authorities or frameworks.

2. By way of derogation from paragraph 1(b), where there is no conclusive evidence of a robust consensus of expert of opinion regarding one or more endpoints, an application shall contain all additional data necessary to show that the substance does not give rise to concern in accordance with Article 28(2) of Regulation (EU) No 528/2012.

SECTION B
An application for inclusion of an active substance in  category B  of  the Simplified Active Substance List under  Regulation (EU) No 528/2012 shall contain the data referred to in Article 6 of that Regulation to allow a state-of-the-art risk assessment.
